NCT00602043 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Patients undergo \[\^18F\] FES PET scan. Patients also undergo standard clinical fludeoxyglucose F 18 (FDG)-PET or FDG-PET/CT scan up to 14 days prior to \[\^18F\] FES PET scan. Patients begin clinically indicated endocrine therapy. Patients are followed-up to determine response on the therapy for 6 months using clinical exams, tumor marker assays, conventional imaging and standard clinical FDG PET/CT. laboratory biomarker analysis: Correlative studies
- id
- FG000
- title
- Diagnostic (FES)
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 20
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 15
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 5
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Patients undergo \[\^18F\] FES PET scan. Patients also undergo standard clinical fludeoxyglucose F 18 (FDG)-PET or FDG-PET/CT scan up to 14 days prior to \[\^18F\] FES PET scan. Patients begin clinically indicated endocrine therapy. Patients are followed-up to determine response on the therapy for 6 months using clinical exams, tumor marker assays, conventional imaging and standard clinical FDG PET/CT. laboratory biomarker analysis: Correlative studies
- id
- FG000
- title
- Diagnostic (FES)
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 20
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 15
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 5
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle